Anavex Life Sciences
AVXL
#7707
Rank
S$0.46 B
Marketcap
S$5.19
Share price
-2.90%
Change (1 day)
-58.08%
Change (1 year)

EPS for Anavex Life Sciences (AVXL)

EPS in 2025 (TTM): S-$0.71

According to Anavex Life Sciences 's latest financial reports the company's current EPS (TTM) is S-$0.70. In 2024 the company made an earnings per share (EPS) of S-$0.67 an increase over its 2023 EPS that were of S-$0.77.

EPS history for Anavex Life Sciences from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$0.715.75%
2024S-$0.67-13.33%
2023S-$0.77-3.23%
2022S-$0.8014.81%
2021S-$0.7020%
2020S-$0.58-16.67%
2019S-$0.7038.46%
2018S-$0.5018.18%
2017S-$0.43-21.43%
2016S-$0.54-35.38%
2015S-$0.84-36.27%
2014S-$1.32112.5%
2013S-$0.62-58.62%
2012S-$1.50-0%
2011S-$1.50-29.27%
2010S-$2.1251.85%
2009S-$1.39-0%
2008S-$1.39237.5%
2007S-$0.41
2006N/A-100%
2005S-$0.05166499.97%
2004S-$0.008610

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ligand Pharmaceuticals
LGND
S$3.09-542.59%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
S-$0.06457-90.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
S$1.29-285.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
S-$38.61 5,437.04%๐Ÿ‡บ๐Ÿ‡ธ USA